Torray LLC Abb Vie Inc. Transaction History

Torray LLC

$678 Million
Q3 2024

A detailed history of Torray LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Torray LLC holds 21,564 shares of ABBV stock, worth $3.67 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

21,564

Previous 21,544 0.09%

Holding current value

$3.67 Million

Previous $3.7 Million 15.24%

% of portfolio

0.63%

Previous 0.57%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$163.84 - $199.33 $3,276 - $3,986	20 Added 0.09%	21,564 $4.26 Million
Q2 2024 Aug 06, 2024	BUY	$154.79 - $180.76 $45,353 - $52,962	293 Added 1.38%	21,544 $3.7 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $9,749 - $11,108	61 Added 0.29%	21,251 $3.87 Million
Q1 2024 May 09, 2024	BUY	$159.82 - $182.1 $94,133 - $107,256	589 Added 2.86%	21,190 $3.86 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $81,046 - $91,277	-589 Reduced 2.78%	20,601 $3.19 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $326,761 - $378,273	2,446 Added 13.05%	21,190 $3.16 Million
Q2 2023 Jul 20, 2023	BUY	$132.51 - $164.9 $3,577 - $4,452	27 Added 0.14%	18,744 $2.53 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $33,115 - $38,137	229 Added 1.24%	18,717 $2.98 Million
Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $33,056 - $39,642	239 Added 1.31%	18,488 $2.99 Million
Q3 2022 Nov 04, 2022	BUY	$134.21 - $153.93 $163,333 - $187,332	1,217 Added 7.15%	18,249 $2.45 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $2.34 Million - $2.98 Million	17,032 New	17,032 $2.61 Million
Q1 2022 May 03, 2022	SELL	$131.98 - $163.75 $2.71 Million - $3.36 Million	-20,529 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $83,365 - $105,481	776 Added 3.93%	20,529 $2.78 Million
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $24,259 - $27,537	228 Added 1.17%	19,753 $2.13 Million
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $6,838 - $7,618	-65 Reduced 0.33%	19,525 $2.2 Million
Q1 2021 May 03, 2021	SELL	$102.3 - $112.62 $2,148 - $2,365	-21 Reduced 0.11%	19,590 $2.12 Million
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $79,363 - $107,148	-986 Reduced 4.79%	19,611 $2.1 Million
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $9,278 - $10,889	108 Added 0.53%	20,597 $1.8 Million
Q2 2020 Aug 03, 2020	SELL	$73.37 - $98.18 $202,868 - $271,467	-2,765 Reduced 11.89%	20,489 $2.01 Million
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $393,127 - $596,030	-6,095 Reduced 20.77%	23,254 $1.77 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $33,396 - $41,785	-463 Reduced 1.55%	29,349 $2.6 Million
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $17,382 - $20,898	276 Added 0.93%	29,812 $2.26 Million
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $169,703 - $216,920	2,583 Added 9.58%	29,536 $2.15 Million
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $208,817 - $245,768	2,707 Added 11.16%	26,953 $2.17 Million
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $294,817 - $363,589	3,787 Added 18.51%	24,246 $2.24 Million
Q3 2018 Nov 02, 2018	BUY	$88.91 - $98.84 $235,166 - $261,431	2,645 Added 14.85%	20,459 $1.94 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $231,991 - $274,498	2,584 Added 16.97%	17,814 $1.65 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $79,956 - $107,069	-869 Reduced 5.4%	15,230 $1.44 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $153,505 - $168,331	1,714 Added 11.92%	16,099 $1.56 Million
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $1 Million - $1.28 Million	14,385	14,385 $1.28 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Torray LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torray LLC with notifications on news.

Account